Is the Hong Kong version of ruxolitinib/ruxolitinib cream better or the Meng version?

Ruxolitinib cream (ruxolitinib) is a topical JAK inhibitor mainly used to treat immune skin diseases such as atopic dermatitis (AD) and vitiligo. As the use of this drug gradually becomes more popular, multiple versions of ruxolitinib cream have appeared on the market, of which the Hong Kong version (usually an imported original drug) and the Meng version (usually a generic drug) are two common choices. Although the main ingredients of the two are the same, they have some different effects on patient selection due to differences in production processes, quality control, price, etc.

From the perspective of efficacy, the Hong Kong version of ruxolitinib cream usually has a relatively stable therapeutic effect, especially when treating immune skin diseases such as vitiligo and atopic dermatitis. It is more effective in reducing local immune reactions and promoting pigment recovery. Since the efficacy data of the original drug has been verified through multiple rounds of clinical trials, most patients can obtain better efficacy and mild side effects after using it.

The efficacy of ruxolitinib cream is also good, but some patients may experience minor side effects due to differences in production processes, such as local allergies, irritation, or dry skin. Generally speaking, the efficacy of generic drugs is almost the same as that of the original drugs, but because different manufacturers may use different excipients or processes, some patients may show slightly different reactions. Nonetheless, the side effects of ruxolitinib cream are generally mild and manageable.

Price is an important factor that patients consider when choosing a drug. The Hong Kong version of ruxolitinib cream is an imported original drug, and its price is relatively high, usually more than 20,000 yuan per box. This may be a significant financial burden for some patients, especially those requiring long-term treatment.

In comparison, the price of Meng version of ruxolitinib cream is relatively low, about between 600-700 yuan. Due to the lower cost of production in Bangladesh and the fact that there is no need to go through the import process, the Bangladeshi version of the drug has a clear advantage in price.

Reference: https://www.opzelura.com/